Draft Guidance Tackles Common Errors In Adverse Event Reporting
This article was originally published in The Gray Sheet
Executive Summary
A revised guidance on medical device reporting fleshes out FDA’s thinking on manufacturers’ responsibilities in various situations.
You may also be interested in...
DexCom Hit With FDA Warning Letter For Adverse Event Deficiencies
The firm says an FDA warning letter it received cites violations based on “recent updates” to FDA’s Medical Device Reporting program made in a draft guidance last year. But FDA emphasizes that it does not take enforcement actions based on how a company implements a guidance document, draft or final.
Industry Says MDR Draft Guidance Would Lead To Redundant Reporting
Industry complained that provisions of FDA’s draft guidance on medical device reporting for manufacturers could lead to duplicative reporting and is unhappy with a requirement to formally request exemptions from MDR reporting.
FDA’s Draft MDR Guidance Looks To Exemption Requests, Leaves Industry Jittery
A draft Medical Device Reporting guidance from FDA has concerned industry experts who say the document would require manufacturers to spend an onerous amount of time submitting requests for exemption from the agency’s MDR regulation.